Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06736925 · ClinicalTrials.gov registry record · NA
Omega-3 Fatty Acids and Subconcussive Head Impacts
A NA study of Omega 3 Fatty Acids and Subconcussive Head Impact, sponsored by Indiana University.
- Recruiting
- Registry status
- NA
- Development phase
- 208
- Enrollment target
- 1
- Study location
NCT06736925 is a NA study of Omega 3 Fatty Acids and Subconcussive Head Impact that is actively recruiting participants, run by Indiana University. The registered enrollment target is 208 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06736925, a NA study of Omega 3 Fatty Acids and Subconcussive Head Impact, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- NA
- Development phase
- 208 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the proposed double-blind, randomized placebo-controlled trial is to understand how supplementation with fish oil \[docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)\] promote brain health against soccer heading. The study involves taking DHA+EPA or placebo, questionnaires, blood draws, brain imaging, tests to evaluate heart function, and soccer headings.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Omega-3 Fatty Acids (EPA plus DHA)
- DIETARY_SUPPLEMENT Organic soybean oil
- OTHER Soccer Heading Model
Study Locations (1)
Indiana
- Indiana University School of Public Health - Bloomington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 208 participants |
| Start Date | 2025-02-28 |
| Est. Completion | 2029-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06736925
The ClinicalTrials.gov registry entry for NCT06736925 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 208 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Omega 3 Fatty Acids appearing as the primary indexed condition, and to 3 interventions - of which Omega-3 Fatty Acids (EPA plus DHA) is the first listed.
NCT06736925 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT06736925 about?
NCT06736925 is a clinical study titled "Omega-3 Fatty Acids and Subconcussive Head Impacts". The purpose of the proposed double-blind, randomized placebo-controlled trial is to understand how supplementation with fish oil \[docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA)\] promote brain health against soccer heading. The study involves taking DHA+EPA or placebo, questionnaires, b...
What is the current status of trial NCT06736925?
This trial is currently recruiting. It is a NA study. The enrollment target is 208 participants. The study started on 2025-02-28. Estimated completion is 2029-05-31.
What conditions does trial NCT06736925 study?
This clinical trial studies the following conditions: Omega 3 Fatty Acids, Subconcussive Head Impact.
What interventions are being tested in trial NCT06736925?
The interventions under investigation include: Omega-3 Fatty Acids (EPA plus DHA) (DIETARY_SUPPLEMENT), Organic soybean oil (DIETARY_SUPPLEMENT), Soccer Heading Model (OTHER).
Who is sponsoring clinical trial NCT06736925?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06736925 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Omega 3 Fatty Acids
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.